TAK ALG-12.5 (Alogliptin Benzoate 12.5 mg)
Pill with imprint TAK ALG-12.5 is Yellow, Elliptical / Oval and has been identified as Alogliptin Benzoate 12.5 mg. It is supplied by Perrigo New York Inc..
Alogliptin is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Alogliptin 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TAK ALG-12.5
Alogliptin Benzoate
- Imprint:
- TAK ALG-12.5
- Strength:
- 12.5 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Perrigo New York Inc.
- National Drug Code (NDC):
- 45802-0103
More about alogliptin
- Alogliptin Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 4 Reviews
- Drug class: dipeptidyl peptidase 4 inhibitors
- FDA Alerts (3)
Consumer resources
Other brands: Nesina
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
